BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31646161)

  • 1. Nonbullous pemphigoid secondary to PD-1 inhibition.
    Singer S; Nelson CA; Lian CG; Dewan AK; LeBoeuf NR
    JAAD Case Rep; 2019 Oct; 5(10):898-903. PubMed ID: 31646161
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
    Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
    JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
    Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
    J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid.
    Wang LL; Moshiri AS; Novoa R; Simpson CL; Takeshita J; Payne AS; Chu EY
    J Am Acad Dermatol; 2020 Jul; 83(1):172-178. PubMed ID: 32068042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
    Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
    Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic testing in gestational bullous pemphigoid: Has enzyme-linked immunosorbent assay replaced direct immunofluorescence as the new gold standard?
    Abel MK; Suresh R; Raffi J; McCalmont TH; Murase JE
    JAAD Case Rep; 2019 Dec; 5(12):1081-1083. PubMed ID: 31799358
    [No Abstract]   [Full Text] [Related]  

  • 9. Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays.
    Gornowicz-Porowska J; Seraszek-Jaros A; Bowszyc-Dmochowska M; Kaczmarek E; Pietkiewicz P; Bartkiewicz P; Dmochowski M
    Postepy Dermatol Alergol; 2017 Feb; 34(1):21-27. PubMed ID: 28261028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
    Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
    J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid.
    Le Saché-de Peufeilhoux L; Ingen-Housz-Oro S; Hue S; Sbidian E; Valeyrie-Allanore L; Ortonne N; Roujeau JC; Wolkenstein P; Chosidow O; André C
    Dermatology; 2012; 224(2):154-9. PubMed ID: 22516798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients.
    Ingen-Housz-Oro S; Plée J; Belmondo T; Maizières M; Pham BN; Hüe S; Ortonne N; Durlach A; Wolkenstein P; Chosidow O; Bernard P
    Dermatology; 2015; 231(1):50-5. PubMed ID: 25871736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
    Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
    Front Immunol; 2019; 10():1934. PubMed ID: 31474998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence.
    Hopkins CR; Ren V; Grover R; Cockerell C; Hsu S
    Cureus; 2022 Feb; 14(2):e22201. PubMed ID: 35308677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.
    Damoiseaux J; van Rijsingen M; Warnemünde N; Dähnrich C; Fechner K; Tervaert JW
    J Immunol Methods; 2012 Aug; 382(1-2):76-80. PubMed ID: 22580378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonbullous pemphigoid: A systematic review.
    Lamberts A; Meijer JM; Jonkman MF
    J Am Acad Dermatol; 2018 May; 78(5):989-995.e2. PubMed ID: 29102490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.